Radformation

Maven Clinic is a virtual healthcare platform founded in 2014 and focused on women's and family health. Operating 24/7, the platform connects members with more than 30 types of specialized providers, covering fertility and family building, maternity and newborn care, parenting and pediatrics, and menopause and midlife health. Clinical, emotional, and financial support are consolidated within a single digital platform, which is available in more than 175 countries. The company has raised over $425 million in funding. Maven distributes its services primarily through employer and health plan partnerships, with more than 2,000 such partners and a total reach of 28 million lives supported. The platform is designed to integrate into existing benefits structures, positioning Maven as a specialist benefits layer for women's and family health rather than a standalone consumer product. The company grounds its clinical claims in a body of research, citing more than 40 peer-reviewed studies. Reported outcomes include up to 27% lower NICU admissions for maternity members and 30% of fertility members achieving pregnancy without assisted reproductive technology. Maven also reports meaningful improvements in maternal mental health among its members. Maven operates across several technical and clinical domains, including telemedicine infrastructure, care navigation, maternal mental health, and clinical outcomes measurement. Its scale - spanning employer benefits integration, a large multi-specialty provider network, and global reach - places it among the more established players in the digital women's health space.

Invivoscribe is a global leader in precision oncology diagnostics, dedicated to improving lives with standardized molecular testing solutions. For over 30 years, the company has pioneered the international standardization of molecular and flow cytometry testing, expanding access to advanced cancer therapies worldwide. Invivoscribe develops and manufactures a comprehensive portfolio of molecular assays, reagents, controls, and bioinformatics tools under ISO 13485 design control, supporting more than 700 clinical laboratories in over 160 countries. The company's Streamlined CDx (companion diagnostic) model accelerates the development of novel therapeutics, enabling personalized approaches to patient care. Invivoscribe's products consistently surpass industry and regulatory standards, playing a crucial role in identifying, stratifying, and monitoring hematologic cancers. Through its subsidiary, the Laboratory for Personalized Molecular Medicine (LabPMM), Invivoscribe offers extensive clinical diagnostic and biopharma services, providing globally standardized flow cytometry and molecular testing services for pharmaceutical and healthcare organizations across the U.S., Europe, and Asia.

IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, employing more than 86,000 people across multiple continents. The company works at the intersection of healthcare data, artificial intelligence, and clinical research - supporting drug development through clinical trials, generating real-world evidence to improve patient outcomes, and helping life sciences organisations make more informed decisions. The technical work spans data science, AI, real-world evidence generation, and the operational infrastructure that moves therapies from research to patients. Teams operate with a stated emphasis on precision and cross-functional collaboration, drawing on large-scale proprietary datasets and analytical capabilities that underpin much of the modern pharmaceutical and healthcare research ecosystem. Internally, IQVIA invests in structured employee development through its Learning Academy, which provides technical training programmes, alongside mentorship opportunities that operate across its global footprint. The company describes its workforce culture as valuing diverse perspectives, flexible working, and recognition of individual contributions at all levels - referring to its employees collectively as "IQVIANs." IQVIA serves clients across the pharmaceutical, biotechnology, and broader life sciences sectors, with its work spanning clinical trial support, health data analytics, and real-world evidence initiatives designed to connect clinical insight with patient impact at scale.

OpenEvidence is an AI-powered medical information platform built for healthcare professionals making clinical decisions at the point of care. Its core product functions as an AI copilot for physicians: clinicians submit clinical questions and receive evidence-based answers, synthesised from trusted medical literature and accompanied by references. The platform is available free to verified U.S. healthcare professionals. The platform has reached considerable scale within the U.S. medical community. More than 40% of U.S. physicians log in daily, and the platform has supported over 100 million AI-powered clinical consultations from doctors and frontline clinicians. OpenEvidence draws on partnerships with leading medical institutions and is designed for use across practice settings, from major hospital systems to rural clinics. The company operates at the intersection of several technical disciplines, including: Natural language processing applied to medical literature Clinical decision support and medical knowledge synthesis HIPAA-compliant health IT infrastructure Evidence-based AI for high-stakes clinical environments OpenEvidence is focused on the United States market and positions itself as a foundational layer for how physicians access and apply medical knowledge in practice.

Vatica Health, founded in 2011 and acquired by Frazier Healthcare Partners in 2023, provides risk adjustment and quality-of-care solutions for health plans and primary care providers across the United States. The company's approach combines proprietary point-of-care technology with in-house clinical teams to improve the accuracy and completeness of clinical documentation and diagnosis code capture - helping healthcare organisations better reflect patient complexity and close gaps in care. Its platform operates across 41 states, serving over 1.7 million patients in partnership with more than 11,000 providers and 14 national and regional health plan clients. The company's primary-care-provider–centred model is designed to integrate into existing clinical workflows, and the company reports an approximate 10% improvement in coding accuracy per patient. Vatica Health has received the Best in KLAS award for risk adjustment software and professional services for three consecutive years, from 2023 through 2025. The company operates at the intersection of healthcare technology and professional clinical services, with core capabilities spanning risk adjustment, healthcare data and analytics, clinical documentation accuracy, and quality measurement. Its workforce includes both software engineers and credentialed clinical professionals, reflecting a model that treats technology and human expertise as complementary rather than interchangeable.

PointClickCare is a founder-led, privately held health technology company that operates a cloud-based care collaboration platform for long-term and post-acute care providers across North America. Its platform connects over 30,000 provider organizations, supporting care coordination, data analytics, and financial management along the post-acute care continuum. The company claims to operate the largest care collaboration network of its kind in North America and describes its dataset as the most comprehensive in the industry. The core platform is extended through a marketplace of more than 400 integrated third-party partners, allowing providers to tailor capabilities to their operational needs. PointClickCare's work spans several technical domains, including electronic health records, artificial intelligence, cloud infrastructure, and data analytics. The company states it reinvests significantly in research and development, and positions AI as a tool for improving both care outcomes and provider productivity. PointClickCare has been recognized by Forbes as a top private cloud company and has been named one of Canada's Most Admired Corporate Cultures. The company describes its internal culture as one that values autonomy, cross-disciplinary collaboration, and a willingness to challenge established approaches. It frames technology as augmenting the human dimension of care rather than displacing it.